Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.15 – $0.23
68% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $12.5M | $13.4M | $10.5M | $18.6M | $19.1M | $16.5M | $25.4M | $18.6M |
| Cost of revenue | $7.1M | $6.9M | $5.9M | $7.5M | $8.0M | $9.0M | $10.0M | $8.7M |
| Gross profit | $5.4M | $6.5M | $4.7M | $11.0M | $11.1M | $7.5M | $15.4M | $9.9M |
| Gross margin | 42.9% | 48.8% | 44.3% | 59.4% | 58.3% | 45.3% | 60.6% | 53.0% |
| R&D | $1.1M | $1.0M | $1.0M | $1.0M | $1.8M | $2.0M | $2.1M | $2.3M |
| Operating income | −$742.8K | $1.1M | −$524.6K | $4.8M | $2.7M | −$2.7M | $3.9M | −$1.6M |
| EBITDA | −$7.1M | $1.7M | −$2.9M | $5.7M | $3.3M | $2.0M | $6.2M | $203.5K |
| Net income | −$8.6M | $31.9K | −$6.2M | $1.6M | $1.8M | −$39.5K | $3.5M | −$2.2M |
| Net margin | -68.9% | 0.2% | -59.2% | 8.8% | 9.4% | -0.2% | 13.9% | -12.1% |
| EPS (diluted) | -0.09 | 0.00 | -0.06 | 0.01 | 0.01 | -0.00 | 0.03 | -0.02 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $18M | $-0.01 | $-0.01–$-0.01 | 1 |
| 2027 | $21M | $0.01 | $0.01–$0.01 | 1 |
| 2028 | $25M | $0.00 | $0.00–$0.00 | 0 |
Forward consensus · source: Financial Modeling Prep
MICROBIX BIOSYSTEMS INC
No one on the platform currently holds MBXBF.
No tracked institution reports a position in MBXBF as of their last filing.
No one on the platform has traded MBXBF yet.
| $17M |
| — |
| ELVAFEvolva Holding S.A. | $2.15 | +0.00% | $16M | — |
| EOFBFEcofibre Ltd. | $0.00 | -98.57% | $378874 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 18.0× earnings vs its 33.7× historical median P/E.
Fair value ≈ $0.38 · price $0.20 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.